Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 6, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-04
DOI
10.1038/s41698-022-00272-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
- (2021) Sujun Chen et al. NATURE CELL BIOLOGY
- Heterogeneity and clonal evolution of acquired PARP inhibitor resistance in TP53- and BRCA1-deficient cells
- (2021) Anniina Färkkilä et al. CANCER RESEARCH
- Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells
- (2021) K. J. Pienta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current status of treatment for colorectal liver metastases in the United Kingdom
- (2021) Kentaro Okamoto et al. Hepatobiliary Surgery and Nutrition
- Resistance to second-generation androgen receptor antagonists in prostate cancer
- (2021) Keith T. Schmidt et al. Nature Reviews Urology
- Growth and differentiation factor 15 and NF‐κB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection
- (2021) Benjamin A. Rybicki et al. Cancer Medicine
- Therapeutic targeting of the hypoxic tumour microenvironment
- (2021) Dean C. Singleton et al. Nature Reviews Clinical Oncology
- The potential of CAR T cell therapy for prostate cancer
- (2021) Philipp Wolf et al. Nature Reviews Urology
- Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre)
- (2021) Eric Felli et al. Hepatobiliary Surgery and Nutrition
- Optimization of immunotherapy for patients with hepatobiliary cancer
- (2021) Yuji Eso et al. Hepatobiliary Surgery and Nutrition
- Revisiting Immunotherapy: A Focus on Prostate Cancer
- (2020) Ha-Ram Cha et al. CANCER RESEARCH
- Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression
- (2020) Ziv Frankenstein et al. Nature Ecology & Evolution
- Dual angiogenesis and PD-1 blockade in hepatocellular carcinoma
- (2020) Julien Calderaro Hepatobiliary Surgery and Nutrition
- The tumor microenvironment
- (2020) Nicole M. Anderson et al. CURRENT BIOLOGY
- Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
- (2020) Rana Mhaidly et al. SEMINARS IN IMMUNOLOGY
- The vascular landscape of human cancer
- (2020) Benjamin M. Kahn et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic and phenotypic heterogeneity in prostate cancer
- (2020) Michael C. Haffner et al. Nature Reviews Urology
- Targeting tumor microenvironment as a treatment strategy for hepatocellular carcinoma
- (2020) Zuyuan Lin et al. Hepatobiliary Surgery and Nutrition
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- Whole Genome and Transcriptional Analysis of Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer Demonstrates Intra-Class Heterogeneity
- (2019) Rahul R. Aggarwal et al. MOLECULAR CANCER RESEARCH
- Cancer stemness, intratumoral heterogeneity, and immune response across cancers
- (2019) Alex Miranda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growth and differentiation factor 15 regulates PD-L1 expression in glioblastoma
- (2019) Haiqing Peng et al. Cancer Management and Research
- Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
- (2019) Mark P. Labrecque et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- Heterogeneity of human prostate carcinoma‐associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment
- (2019) Renee E. Vickman et al. PROSTATE
- PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
- (2019) Sylvie M. Noordermeer et al. TRENDS IN CELL BIOLOGY
- The tip of the iceberg: predicting PARP inhibitor efficacy in prostate cancer
- (2019) Silke Gillessen et al. LANCET ONCOLOGY
- Now the dust has settled over immune checkpoint blockade in metastatic prostate cancer
- (2018) N Mehra et al. ANNALS OF ONCOLOGY
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing
- (2018) Fei Su et al. EUROPEAN UROLOGY
- The long tail of oncogenic drivers in prostate cancer
- (2018) Joshua Armenia et al. NATURE GENETICS
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Bladder cancer: Neuroendocrine disease genomics
- (2018) Clemens Thoma Nature Reviews Urology
- Cellular plasticity and the neuroendocrine phenotype in prostate cancer
- (2018) Alastair H. Davies et al. Nature Reviews Urology
- Intratumor heterogeneity in epigenetic patterns
- (2018) Yassen Assenov et al. SEMINARS IN CANCER BIOLOGY
- Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
- (2018) Emelie Berglund et al. Nature Communications
- Genetic Mechanisms of Immune Evasion in Colorectal Cancer
- (2018) Catherine S. Grasso et al. Cancer Discovery
- Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression
- (2018) Filippo Cortesi et al. Cell Reports
- Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity
- (2018) Marthe Løvf et al. EUROPEAN UROLOGY
- Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
- (2018) Manabu Kato et al. ONCOGENE
- Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
- (2018) Priyamvada Jayaprakash et al. JOURNAL OF CLINICAL INVESTIGATION
- Bone marrow–derived fibroblasts are a functionally distinct stromal cell population in breast cancer
- (2018) Yael Raz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
- (2018) Paola Francica et al. Genome Medicine
- Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
- (2018) Wassim Abida et al. JAMA Oncology
- Cancer associated fibroblasts: is the force the path to the dark side?
- (2018) Jorge Barbazán et al. CURRENT OPINION IN CELL BIOLOGY
- NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development
- (2017) Nivedita M. Ratnam et al. JOURNAL OF CLINICAL INVESTIGATION
- Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis
- (2017) Qiang Liu et al. Molecular Cancer
- Adrenergic nerves activate an angio-metabolic switch in prostate cancer
- (2017) Ali H. Zahalka et al. SCIENCE
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
- (2017) Guan-Zhong Qiu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors
- (2017) David Quigley et al. Cancer Discovery
- Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling
- (2017) Bridgette F. Peake et al. Oncotarget
- Transforming growth factor β as regulator of cancer stemness and metastasis
- (2016) Claudia Bellomo et al. BRITISH JOURNAL OF CANCER
- Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification
- (2016) David S. Priemer et al. ENDOCRINE PATHOLOGY
- Stromal factors involved in human prostate cancer development, progression and castration resistance
- (2016) Noemi Eiro et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The impact of hypoxia on tumor-associated macrophages
- (2016) Anne-Theres Henze et al. JOURNAL OF CLINICAL INVESTIGATION
- ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
- (2016) Jill E. Larsen et al. JOURNAL OF CLINICAL INVESTIGATION
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Towards effective combination of ADT and immunotherapy
- (2016) Clemens Thoma Nature Reviews Urology
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers
- (2015) A. M. Aparicio et al. CLINICAL CANCER RESEARCH
- Spatial genomic heterogeneity within localized, multifocal prostate cancer
- (2015) Paul C Boutros et al. NATURE GENETICS
- Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
- (2015) Colin S Cooper et al. NATURE GENETICS
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
- (2015) Nicholas McGranahan et al. Science Translational Medicine
- Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
- (2015) A. Morello et al. Cancer Discovery
- Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals
- (2015) Hongjun Xie et al. Oncotarget
- Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis
- (2014) Tania Valencia et al. CANCER CELL
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15
- (2014) F. Bruzzese et al. CANCER RESEARCH
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
- (2014) M. Ammirante et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate
- (2014) James R. Lambert et al. PROSTATE
- The role of reactive oxygen species and metabolism on cancer cells and their microenvironment
- (2014) Ana Costa et al. SEMINARS IN CANCER BIOLOGY
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
- (2013) I. B. Barsoum et al. CANCER RESEARCH
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer
- (2012) Xingya Wang et al. BIOCHEMICAL PHARMACOLOGY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Exome Sequencing of Prostate Cancer Supports the Hypothesis of Independent Tumour Origins
- (2012) Johan Lindberg et al. EUROPEAN UROLOGY
- Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
- (2012) Mallika Singh et al. NATURE BIOTECHNOLOGY
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Growth/differentiation factor-15: prostate cancer suppressor or promoter?
- (2012) P Vaňhara et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth
- (2011) Michael Quante et al. CANCER CELL
- Role for Stromal Heterogeneity in Prostate Tumorigenesis
- (2011) M. A. Kiskowski et al. CANCER RESEARCH
- Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis
- (2011) Omar E. Franco et al. CANCER RESEARCH
- CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
- (2011) Barbara Savoldo et al. JOURNAL OF CLINICAL INVESTIGATION
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- GDF-15 Contributes to Proliferation and Immune Escape of Malignant Gliomas
- (2010) P. Roth et al. CLINICAL CANCER RESEARCH
- Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
- (2010) X. Lu et al. CLINICAL CANCER RESEARCH
- Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
- (2010) Matei Andreoiu et al. HUMAN PATHOLOGY
- Therapeutic targeting of the prostate cancer microenvironment
- (2010) Maria Karlou et al. Nature Reviews Urology
- Autocrine TGF- and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
- (2010) Y. Kojima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer
- (2009) D. A. Brown et al. CLINICAL CANCER RESEARCH
- EMT: When epithelial cells decide to become mesenchymal-like cells
- (2009) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- A luminal epithelial stem cell that is a cell of origin for prostate cancer
- (2009) Xi Wang et al. NATURE
- Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
- (2009) Wennuan Liu et al. NATURE MEDICINE
- The Extracellular Matrix: Not Just Pretty Fibrils
- (2009) R. O. Hynes SCIENCE
- Tumor–stroma co-evolution in prostate cancer progression and metastasis
- (2009) Sajni Josson et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
- (2008) P. J. Mishra et al. CANCER RESEARCH
- Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing
- (2008) K. S. Sfanos et al. CLINICAL CANCER RESEARCH
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
- (2008) Martin A Pule et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now